Cooperative ProductionPeer-to-Peer MarketplaceDecentralized Coordinationmedium
Transparent Cooperative PBM Clearinghouse
A cooperative PBM clearinghouse could publish formulary criteria, pass through net prices and rebates, route claims through open APIs, and give employers, unions, public purchasers, and independent pharmacies shared governance over purchasing rules.
Thesis
The concept attacks the PBM moat by separating drug-purchasing coordination and claims routing from opaque vertically integrated rebate economics.
Bitcoin / decentralization role
Decentralization matters through cooperative governance, transparent rule publication, and multi-party audit trails; Bitcoin is not central unless later used for payment settlement or bond-based anti-fraud incentives.
Coordination mechanism
Purchasers pool demand, pharmacies publish fulfillment terms, manufacturers or wholesalers submit net-price offers, and the cooperative clearinghouse applies member-approved formulary and reimbursement rules.
Verification / trust model
Net-price schedules, rebate receipts, spread-pricing bans, formulary exceptions, and pharmacy reimbursements would be logged for member audit; false fulfillment is constrained by pharmacy licensure, claims reconciliation, inventory records, and independent audit rights.
Failure modes
- • Large manufacturers may refuse attractive pricing without incumbent PBM volume.
- • A cooperative clearinghouse could still become opaque if audit rights and member governance are weak.
- • Regulatory, fiduciary, HIPAA, ERISA, and state pharmacy-benefit laws could make rollout slow and jurisdiction-specific.
Adoption path
- • Begin with transparent pass-through PBM services for self-funded employers and union plans.
- • Add independent pharmacy participation with published reimbursement logic and claims reconciliation.
- • Use purchasing scale and audited savings to attract public plans or regional coalitions.
Decentralization fit
63.0/10
The model distributes governance and audit rights across purchasers and pharmacies, but still depends on regulated intermediaries and negotiated drug supply.
Coordination credibility
56.0/10
The FTC's PBM scrutiny identifies a clear problem and pass-through PBM models already exist conceptually, but coalition formation and manufacturer participation are hard.
Implementation feasibility
46.0/10
Claims routing, audits, and formularies are technically feasible, but compliance, contracting, drug supply, and capital requirements make implementation difficult.
Incumbent pressure
51.0/10
A credible transparent cooperative PBM could pressure pricing and rebate opacity for self-funded purchasers, but Evernorth's scale and specialty pharmacy assets remain substantial advantages.
Sources
Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street PharmaciesFTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug PricesCMS Interoperability and Prior Authorization Final Rule CMS-0057-FTrusted Exchange Framework and Common AgreementGNU Health DownloadOur Capabilities